Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

NCT03573310

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Florida Specialist and Cancer Institute Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Ohio State University Columbus, Ohio, United States
  • University of Texas, MD Anderson Cancer Center Houston, Texas, United States
View all 18 locations
View Trial Details
Completed

Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

NCT02461888

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Queen Elizabeth Medical Centre Birmingham, United Kingdom
  • Heart of England NHS Foundation Trust Birmingham, United Kingdom
  • Royal Bournemouth General Hospital Bournemouth, United Kingdom
  • University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom
View all 18 locations
View Trial Details
Completed

FT576 in Subjects With Multiple Myeloma

NCT05182073

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Scri-Cbci Denver, Colorado, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
View all 14 locations
View Trial Details

Related conditions